Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.92
-0.07 (-0.78%)
At close: Mar 18, 2026, 4:00 PM EDT
8.86
-0.06 (-0.67%)
After-hours: Mar 18, 2026, 4:06 PM EDT
Bioventus Revenue
In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%. Bioventus had revenue of $157.90M in the quarter ending December 31, 2025, with 2.77% growth.
Revenue (ttm)
$568.09M
Revenue Growth
-0.91%
P/S Ratio
1.06
Revenue / Employee
$610,846
Employees
930
Market Cap
600.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 568.09M | -5.19M | -0.91% |
| Dec 31, 2024 | 573.28M | 60.94M | 11.89% |
| Dec 31, 2023 | 512.35M | 228.00K | 0.04% |
| Dec 31, 2022 | 512.12M | 81.22M | 18.85% |
| Dec 31, 2021 | 430.90M | 109.74M | 34.17% |
| Dec 31, 2020 | 321.16M | -18.98M | -5.58% |
| Dec 31, 2019 | 340.14M | 20.96M | 6.57% |
| Dec 31, 2018 | 319.18M | 65.53M | 25.83% |
| Dec 31, 2015 | 253.65M | 10.76M | 4.43% |
| Dec 31, 2014 | 242.89M | 10.52M | 4.53% |
| Dec 31, 2013 | 232.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.64B |
| Varex Imaging | 854.40M |
| Orthofix Medical | 822.31M |
| Avanos Medical | 701.20M |
| Tactile Systems Technology | 329.52M |
| Axogen | 225.21M |
| Cytek Biosciences | 201.49M |
| SI-BONE | 200.93M |
BVS News
- 13 days ago - Bioventus Inc. (BVS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 21 days ago - Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 - GlobeNewsWire
- 2 months ago - Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PRNewsWire
- 4 months ago - Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Bioventus Inc. (BVS) Q3 2025 Earnings Call Transcript - Seeking Alpha